Grey Wolf Therapeutics
Clinical trials sponsored by Grey Wolf Therapeutics, explained in plain language.
-
New pill aims to tame back and joint inflammation
Disease control Recruiting nowThis study tests an experimental pill called GRWD0715 for people with axial spondyloarthritis, a condition that causes long-term inflammation in the spine and pelvic joints. The trial starts with healthy volunteers to check safety, then moves to patients to see if the drug reduce…
Phase: PHASE1, PHASE2 • Sponsor: Grey Wolf Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New cancer drug combo trial opens for advanced solid tumors
Disease control Recruiting nowThis study tests a new drug called GRWD5769, given alone or with another cancer drug, for people with advanced solid tumors that have not responded to other treatments. The main goals are to check safety and find the best dose. About 300 adults will take part in this early-phase …
Phase: PHASE1, PHASE2 • Sponsor: Grey Wolf Therapeutics • Aim: Disease control
Last updated May 12, 2026 13:41 UTC